drugdiscoverynews.com

.com crawl

First seen 2026-04-14 · Last seen 2026-05-18 · ok HTTP/1.1 200 1152 ms crawled 2026-05-07

CA · 216.223.155.118 · AS12059 Internet Light and Power Inc.

Reputation 94/100 dmarc monitor-only

Classifying

HTML metadata

Title
Drug Discovery News, Development & Diagnostics Articles | DDN Magazine
Description
DDN provides engaging stories about scientific breakthroughs to help life science researchers develop diagnostic and therapeutic approaches for improving human health.
Language
en
Canonical
https://www.drugdiscoverynews.com/

Open Graph

url
https://www.drugdiscoverynews.com/
title
Drug Discovery News, Development & Diagnostics Articles | DDN Magazine
site name
Drug Discovery News
description
DDN provides engaging stories about scientific breakthroughs to help life science researchers develop diagnostic and therapeutic approaches for improving human health.

Technology

CDN
Amazon CloudFront
CMS
Next.js

Third-party hosts loaded (1)

  • dev.visualwebsiteoptimizer.com×1

Social

Registration

Registrar
GoDaddy.com, LLC
Created
2004-09-22
Expires
2026-09-22 124 days left
Updated
2025-09-23
Name servers
  • ns11.constellix.com
  • ns21.constellix.com
  • ns31.constellix.com
  • ns41.constellix.net
  • ns51.constellix.net
  • ns61.constellix.net

DNS records live

NS
  • ns11.constellix.com
  • ns21.constellix.com
  • ns31.constellix.com
  • ns41.constellix.net
  • ns51.constellix.net
  • ns61.constellix.net
MX
  • 1 aspmx.l.google.com
  • 10 alt3.aspmx.l.google.com
  • 10 alt4.aspmx.l.google.com
  • 5 alt1.aspmx.l.google.com
  • 5 alt2.aspmx.l.google.com
TXT
  • gy6gf22947h1b90ld10s5yk5w7129h9f
Verified for
  • Atlassian
  • Google

Email authentication partial

SPF
v=spf1 ip4:216.223.155.112/28 ip4:66.159.123.64/28 include:_spf.google.com include:547446.spf07.hubspotemail.net ~all
softfail (~all)
DMARC
v=DMARC1; p=none; rua=mailto:dmarc.reports@labx.com; ruf=mailto:dmarc.reports@labx.com; sp=none; fo=0:1:d:s;
policy: none (monitoring only) · sp=none
DKIM
  • google: v=DKIM1; k=rsa; p=MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAhaLXf8plsbRIbURphD5dUgtolwXte9NhB3bSbWKJcKMWO1/1cXZQUlKtS42d3M8JKloKIwDLa6UupT…
  • s1: k=rsa; t=s; p=MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEArSJ35Juyr4JbgSeywffdPWr5sjmvxdvU9wKGJd771SNTquuzvSaFC20k6D68vkxPZ50ATHCcyff+ZYRyUy…
  • s2: k=rsa; t=s; p=MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEA3bHqcaa0EqWAqkQxb0eEGG0zNOG8iyZtXq9i4XQ8AYGUfLmJmwl5wu2OWyCMbRPHsp/BTtyPcHumO5iSq3…
selectors probed

Certificate (current)

E8
from 2026-03-19 to 2026-06-17
Expires in 28 days

HTTP security headers

Header hygiene 60/100 Checked live page: https://www.drugdiscoverynews.com/

present
  • strict-transport-security
  • x-content-type-options
  • referrer-policy
findings
  • short HSTS max-age
  • missing Content Security Policy
  • missing frame protection
  • missing Permissions Policy
Header values
referrer-policy
strict-origin-when-cross-origin
x-content-type-options
nosniff
strict-transport-security
max-age=300; includeSubDomains

Links to (4)

Linked from (2)